In head and neck squamous cell carcinoma, the oncogene FOXM1, a downstream target of the oncogenic SHH signaling pathway, upregulates HELLS, and HELLS is then responsible for promoter hypermethylation of tumor suppressors such as CDKN2A [59]. This evidence concerns the gene HELLS and head and neck squamous cell carcinoma.